Careers Header Bg
Regask Raps
REGASK SPONSORS

RAPS 2025 Regulatory Intelligence Conference

MARCH 13-14, 2025  |  BALTIMORE, MARYLAND, USA

Hilton Baltimore BWI Airport

Meet us at RAPS 2025!

Meet our team

Join Amenallah Reghimi, Kelli Madden, and JD Deleon at the RegASK booth to explore how our AI-driven regulatory intelligence is transforming compliance strategies.

Learn more with them about –

  • The game-changing role of AI in revolutionizing regulatory intelligence
  • How RegASK’s cutting-edge technology is streamlining regulatory workflows
  • How our AI-driven solutions can empower your organization to stay ahead of evolving global regulations.
Raps Conference Attendees

JD Deleon

Business Development Director

Amenallah Reghimi

Chief Product and Technology Officer

Kelli Madden

Senior Regulatory Intelligence Manager



Bg Flip Card 1

RAPS 2025, A Premier Gathering of Industry Leaders

The Regulatory Intelligence Conference 2025 will bring together global regulatory professionals, industry leaders, and AI-driven solution providers.

This premier event will serve as a dynamic platform for knowledge exchange, innovative discussions, and collaborative problem-solving.

Key events of the conference

 
Exploring the Future of Regulatory Intelligence

The conference will kick off with an insightful seminar on The Evolving Role of Regulatory Intelligence from Emerging Field to Core Competency. Experts will discuss how regulatory intelligence is transitioning from a support function to a strategic necessity, and industry leaders will share perspectives on leveraging AI and technology to enhance regulatory decision-making.

 
Diving Into Key Regulatory Challenges

Throughout the conference, attendees will address critical regulatory challenges, such as:

  • Navigating Global Regulatory Policy & Intelligence in Large Organizations
  • Harnessing Regulatory Intelligence for Global Compliance
  • Harnessing the Power of Collaboration: Explore a Unique Therapeutic Area (TA)-Focused Regulatory Intelligence (RI) Model
 
Closing with a Vision for the Future

The event will conclude with a compelling seminar on Empowering Decision-Making: The Role of Regulatory Intelligence Professionals in Evaluating Vendors and Solutions.

This session will emphasize the importance of regulatory intelligence in shaping business strategies and ensuring informed vendor selections.

Meet us at RAPS 2025!

Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more